Millipore Opens $50M R&D Center

Millipore Corp. has opened a new $50 million R&D center in Bedford, MA as part of its strategy to leverage cutting edge technologies, extend its applications expertise, and to meet the growing demands of the global biopharmaceutical market and the life sciences industry.

“Our new Bioprocess R&D Center is a demonstration of our commitment to MA and our continuing investment in technologies and facilities that will help us to deliver innovative, quality products to our customers,” said Martin Madaus, chairman and chief executive officer of Millipore. “Over the past two years, we have begun to transform Millipore into a more innovative organization with new capabilities to meet the changing needs of our industry. The opening of this center continues this transformation, enabling us to attract the best scientific talent and bring together multiple research disciplines to develop integrated solutions. These solutions will create value for our biotechnology and pharmaceutical customers and fuel our continued growth as a leader in the life sciences industry.”

The Bioprocess division is designed to help companies optimize manufacturing productivity, ensure the quality of drugs, and scale up the production of difficult-to-manufacture biologics. Also, with this new center, the company is able to develop full-scale applications performance data and processes that simulate commercial conditions that can result in increased speed and quality of biopharmaceutical production.

The state-of-the-art 110,000 sq.-ft. building contains 47,000 sq.-ft. of lab space, and consolidates multiple functions. As many as 500 professionals will work in the new facility.